# Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

> **NCT01691560** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 140 (actual)

## Conditions studied

- Dentine Hypersensitivity

## Interventions

- **DRUG:** 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
- **DRUG:** 0% calcium sodium phosphosilicate/sodium monofluorophosphate dentifrice
- **DRUG:** Sodium monofluorophosphate dentifrice
- **DRUG:** Sodium fluoride dentifrice

## Key facts

- **NCT ID:** NCT01691560
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2014-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01691560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01691560, "Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01691560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*